Greater Dose-Ranging Effects on A1C Levels Than on Glucosuria With LX4211, a Dual Inhibitor of SGLT1 and SGLT2, in Patients With Type 2 Diabetes on Metformin Monotherapy
Diabetes Care. 2015;38(3)431-8 http://care.diabetesjournals.org/content/38/3/431?etoc
Leggi


